• HOME>
  • News Releases>
  • Sumitomo Pharmaceuticals

News Releases

Sumitomo Pharmaceuticals

2005

  • Jul. 6, 2005
    Sumitomo Pharmaceuticals Signs Agreement with Merck & Co., Inc. Forming Global Partnership for SM13496 (lurasidone), an Atypical Antipsychotic Compound
  • Jun. 30, 2005
    Sumitomo Licenses an Antitumor Drug, Amrubicin Hydrochloride, to Conforma
  • May 18, 2005
    Sumitomo Licenses Breakthrough Antibiotic SMP-601 to Prote
  • Apr. 28, 2005(PDF/30KB)
    Dainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000